# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-280270
Filing Date
2025-11-13
Accepted
2025-11-13 16:30:57
Documents
63
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sybx-20250930.htm iXBRL | 10-Q | 1852796
2 | EX-31.1 | sybx-ex31_1.htm | EX-31.1 | 15636
3 | EX-31.2 | sybx-ex31_2.htm | EX-31.2 | 15516
4 | EX-32 | sybx-ex32.htm | EX-32 | 7296
| Complete submission text file | 0001193125-25-280270.txt |  | 7377610

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | sybx-20250930.xsd | EX-101.SCH | 1171867
65 | EXTRACTED XBRL INSTANCE DOCUMENT | sybx-20250930_htm.xml | XML | 1179409

Mailing Address PO BOX 30 WINCHESTER MA 01890
Business Address PO BOX 30 WINCHESTER MA 01890 617-659-2802
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 251479087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)